Aug 2026 · Transcript
Source: Bse
Chemicals stocks · Large cap · NSE
Gujarat Fluorochemicals Ltd. (GFCL) is a leading Indian chemicals company, India's largest integrated fluoropolymer producer, supplying fluoropolymers and fluorochemicals globally. It is developing products for new-age businesses like EVs, BESS, and green hydrogen, leveraging its 30 years of fluorine chemistry expertise.
SMA20 -3.9% / mo · MACD − · sector -5.7pp vs Nifty 500 (3M)
Latest FPI flow is positive, but a second consecutive positive fortnight is still required. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +24.0% · PAT +20.3% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +24% YoY · PAT +20% YoY · +16% QoQ · margin compression
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,588 Cr | +24.0% | +16.0% |
| EBITDA | ₹426 Cr | +23.8% | +38.8% |
| Operating margin | 27.0% | +0 bps | +500 bps |
| PAT | ₹219 Cr | +20.3% | +119.0% |
| PAT margin | 13.8% | -42 bps | +649 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 22/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term uptrend intact. RSI 43.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 36 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4FY26 consolidated revenue grew 12% YoY to Rs. 1,369 Cr, driven by the Chemical segment (up 11%). Consolidated EBITDA rose only 1% YoY to Rs. 308 Cr, while PAT declined 32% YoY to Rs. 112 Cr, impacted by losses in the new Battery Materials segment.
Consolidated PAT declined sharply due to significant losses in the nascent Battery Materials segment, which is still in its pre-commercialization phase. While the Chemical segment showed robust growth, the substantial capex in battery materials is yet to yield returns, impacting near-term profitability.
Latest issuer-disclosed distribution across 2 reported categories.
Global fluoropolymer demand is expected to remain strong, driven by rising applications in semiconductors, EVs/BESS, and clean energy sectors.
R32 production and sales commenced from March 2026. Demand for refrigerants is expected to remain healthy, supported by increasing penetration of residential air-conditioning and cooling infrastructure for AI/Data centers.
EV/BESS demand is growing rapidly, with ex-China LiB cell demand expected to grow from 500 GWh in CY26 to ~1.8 TWh by CY30. LiPF6 has orders in place for FY27 and beyond.
High-performance fluoropolymers like PFA and FKM are expected to grow faster, led by semiconductor fabs, AI-driven data center expansion, and advanced automotive applications.
R32 production and sales commenced from March 2026.
All the initial capacity planned in Phase I for battery materials has been commissioned and contracted for.
The company is setting up an NGAAM (Anode) facility, which will cover 70% value of LFP cell cost.
Samples from the LFP (CAM) plant have received initial approvals, with commercial sales expected to start in H2FY27.
EV/BESS demand is growing at a rapid pace, with ex-China LiB cell demand expected to grow from 500 GWh in CY26 to ~1.8 TWh by CY30.
Prices have firmed up for all battery materials over the last two quarters.
Global fluoropolymer demand is expected to remain strong, driven by rising applications in semiconductors, EVs/BESS, and clean energy sectors.
The pricing environment for HFCs remains favorable, supported by disciplined global supply dynamics and healthy demand across key end markets.
The Fluorochemicals segment faced a challenging global environment and weakness in the Middle East market.
Demand outlook for caustic soda is expected to remain stable in FY27, but pricing is likely to remain range-bound due to domestic capacity additions.
The Battery Materials segment reported significant negative EBITDA of Rs. -45 Cr and PAT of Rs. -57 Cr in Q4FY26, impacting consolidated results.
The full potential of the Rs. 6,000 Cr capex for battery materials is expected to be realized only in FY29, indicating a long gestation period.
LFP CAM and PVDF Binder are still in qualification/approval stages, with commercial sales expected in H2FY27 and H1FY27 respectively, posing execution risk.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is essential to account for potential seasonality in chemical demand and pricing. QoQ comparison is also relevant to assess sequential momentum, particularly for new product ramp-ups like R32 and the nascent Battery Materials segment.
Consolidated EBITDA Margin for Q4FY26 stood at 22%, a decrease of 248 bps compared to 25% in Q4FY25.
Chemical segment EBITDA Margin for Q4FY26 stood at 26%, an increase of 52 bps compared to 25% in Q4FY25.
Working Capital Days remained stable at 100 days in FY26, consistent with FY25.
Planned Rs. 2,300 Cr capex for FY27 across the battery material portfolio, largely growth capex including for NGAAM.
LFP CAM samples received initial approvals, commercial sales expected in H2FY27. PVDF Binder qualification complete, commercial business expected in H1FY27.
Planned Rs. 2,300 Cr capex for FY27. Overall capex Rs. 6,000 Cr by FY28, targeting 2x Asset turnover and 25%+ EBITDA margin by FY29.
Continued focus on optimizing HFC production and incremental capacity expansion to utilize entitlements under the Kigali Amendment.
To be the global leader in battery materials, garnering the largest share of the EV/ESS battery wallet, with a fully integrated complex in Jolva.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Battery Materials Commercial Sales | LFP CAM samples approved, PVDF Binder qualification complete. | Commencement and ramp-up of commercial sales for LFP CAM (H2FY27) and PVDF Binder (H1FY27). |
| Battery Materials Capex Utilization & Returns | Rs. 2,300 Cr capex planned for FY27, Rs. 6,000 Cr by FY28. | Progress on capex deployment and achievement of 2x asset turnover and 25%+ EBITDA margin by FY29. |
| Consolidated Profitability | Q4FY26 Consolidated PAT down 32% YoY. | Improvement in consolidated PAT as the Battery Materials segment scales up and turns profitable. |
| Fluoropolymers Growth | Revenue up 19% YoY and 14% QoQ. | Sustained strong growth in fluoropolymers, especially high-performance grades, driven by new applications. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Gujarat Fluorochemicals Limited plans to invest approximately Rs 6,000 crore over the next 4-5 years to build large-scale battery materials manufacturing capacity.
"Investing ~ Rs 6,000 crs over the next 4-5 years"
Gujarat Fluorochemicals Limited plans to invest approximately Rs 6,000 crore over the next 4-5 years to build large-scale battery materials manufacturing capacity.
"Investing ~ Rs 6,000 crs over the next 4-5 years"
The company is further expanding its LiPF6 capacities to meet growing demand.
"are further expanding our capacities to meet growing demand"
The company is further expanding its LiPF6 capacities to meet growing demand.
"are further expanding our capacities to meet growing demand"
LiPF6 sales are expected to commence soon.
"In LiPF₆ sales to commence soon"
LiPF6 sales are expected to commence soon.
"In LiPF₆ sales to commence soon"
Outcome check: Revenue YoY averaged 5.4% across 2 later quarter(s).
Sales of fluoropolymer binders are expected to commence from first half of CY26.
"expecting sales to commence from first half of CY26"
Sales of fluoropolymer binders are expected to commence from first half of CY26.
"expecting sales to commence from first half of CY26"
Outcome check: Revenue YoY averaged 5.4% across 2 later quarter(s).
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Management has 100% delivered/partly-delivered outcomes on 2 checked claims. It ranks around the 66th percentile of the scored universe and 47th percentile within Chemicals. Main check: financial discipline is weak at 52/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 47th pctile, median 73 · Large: 42nd pctile, median 73
100 documents have extracted text, but claim history is not strong enough yet.
2/4 claims checked · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse